The findings suggest that rAd-p53 treatment is safe, practical, and very successful in treating not only human head and neck squamous cell carcinoma,36,37 but also other cancers such as liver cancer,48,49 lung cancer,50,51 ovarian cancer,38 and breast cancer. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.